NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $55,196 | -29.2% | 24,423 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $78,000 | -25.0% | 24,423 | -10.9% | 0.01% | -28.6% |
| Q2 2022 | $104,000 | +38.7% | 27,412 | +97.1% | 0.01% | +40.0% |
| Q1 2022 | $75,000 | -88.0% | 13,906 | -59.5% | 0.01% | -78.3% |
| Q3 2019 | $626,000 | -11.3% | 34,367 | +73.3% | 0.05% | -17.9% |
| Q2 2019 | $706,000 | +6.0% | 19,834 | 0.0% | 0.06% | -11.1% |
| Q1 2019 | $666,000 | -2.9% | 19,834 | -5.0% | 0.06% | +12.5% |
| Q4 2018 | $686,000 | +259.2% | 20,878 | +34.0% | 0.06% | +194.7% |
| Q1 2017 | $191,000 | 0.0% | 15,584 | 0.0% | 0.02% | -26.9% |
| Q4 2016 | $191,000 | – | 15,584 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |